Arnulfo Mendoza
- Cancer Research top 5%
- Cancer, Hypoxia, and Metabolism 8
- Immunology and Allergy top 2%
- Oncology top 5%
- Cancer Cells and Metastasis 5
- PARP inhibition in cancer therapy 4
- CAR-T cell therapy research 4
-
- Sarcoma Diagnosis and Treatment 13
- Molecular Biology top 5%
- PI3K/AKT/mTOR signaling in cancer 5
- Ubiquitin and proteasome pathways 5
-
- Multiple Myeloma Research and Treatments 4
Arnulfo Mendoza
48 papers receiving 2.7k citations
Hit Papers
Peers
Comparison fields: 5 of 101
- Cancer Research 636
- Immunology and Allergy 223
- Oncology 965
- Pulmonary and Respiratory Medicine 789
- Molecular Biology 1.5k
Countries citing papers authored by Arnulfo Mendoza
This map shows the geographic impact of Arnulfo Mendoza's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Arnulfo Mendoza with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Arnulfo Mendoza more than expected).
Fields of papers citing papers by Arnulfo Mendoza
This network shows the impact of papers produced by Arnulfo Mendoza. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Arnulfo Mendoza. The network helps show where Arnulfo Mendoza may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Arnulfo Mendoza, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2024 | 2 | |
| 2 | 2023 | 11 | |
| 3 | 2020 | 25 | |
| 4 | 2020 | 36 | |
| 5 | 2020 | 22 | |
| 6 | 2019 | 20 | |
| 7 | 2019 | 43 | |
| 8 | 2017 | 50 | |
| 9 | 2016 | 22 | |
| 10 | 2016 | 10 | |
| 11 | 2015 | 40 | |
| 12 | 2013 | 60 | |
| 13 | 2012 | 23 | |
| 14 | 2011 | 43 | |
| 15 | 2011 | 164 | |
| 16 | 2010 | 74 | |
| 17 | 2008 | 32 | |
| 18 | 2008 | 13 | |
| 19 | 2007 | 73 | |
| 20 | 2007 | 202 |
About Arnulfo Mendoza
Arnulfo Mendoza is a scholar working on Immunology and Allergy, Oncology and Cancer Research, having authored 51 papers that have together received 2.8k indexed citations. Recurring topics across this work include Sarcoma Diagnosis and Treatment (13 papers), Cancer, Hypoxia, and Metabolism (8 papers), PI3K/AKT/mTOR signaling in cancer (5 papers), Cancer Cells and Metastasis (5 papers), Ubiquitin and proteasome pathways (5 papers), Multiple Myeloma Research and Treatments (4 papers), PARP inhibition in cancer therapy (4 papers) and CAR-T cell therapy research (4 papers). The work is most often cited by research in Cancer Research (636 citations), Immunology and Allergy (223 citations) and Oncology (965 citations). Arnulfo Mendoza has collaborated with scholars based in United States, Canada and China. Frequent co-authors include Chand Khanna, Lee J. Helman, Xiaolin Wan, Choh Yeung, Stephen M. Hewitt, Richard Görlick, Ryan D. Cassaday, Osarenoma Olomu, Ling Ren and Na Shen. Their work appears in journals such as Journal of Clinical Investigation, Nature Medicine and Nature Communications.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.